Assess whether observed collection is justified and documented (1aaae8)

Situation

Split-specimen B bottle request timeline arrived with a collector who skipped the bluing agent for oral-fluid implementation lead. That is a Forensic Drug Testing Program Design and Audit decision on observed collection is justified in a federal contractor under an HHS-mandatory program.

Decision

Oral-fluid implementation lead in a federal contractor under an HHS-mandatory program must choose Accept the result / Reject on custody / Recollect / Hold using split-specimen B bottle request timeline after a collector who skipped the bluing agent.

Hypotheses to test

• Authorize Accept the result now; split-specimen B bottle request timeline already has the discriminator after a collector who skipped the bluing agent.
• Keep Reject on custody in force until split-specimen B bottle request timeline is completed after a collector who skipped the bluing agent for oral-fluid implementation lead.
• Treat split-specimen B bottle request timeline as Recollect because both readings appear after a collector who skipped the bluing agent.
• Refuse a Forensic Drug Testing close: oral-fluid implementation lead does not have the page observed collection is justified turns on in split-specimen B bottle request timeline.

Analysis required

• Confirm the kit ID in split-specimen B bottle request timeline matches the collection log.
• Check MRO notes and cutoffs against the protocol a federal contractor under an HHS-mandatory program claims to run.
• Walk chain of custody, collection site, and validity flags in split-specimen B bottle request timeline after a collector who skipped the bluing agent.
• For this Forensic Drug Testing Program Design and Audit file, read split-specimen B bottle request timeline against a collector who skipped the bluing agent and write the one fact that would move observed collection is justified for oral-fluid implementation lead.

Recommendation

Choose Accept the result / Reject on custody / Recollect / Hold on this Forensic Drug Testing / Program Design and Audit packet (split-specimen B bottle request timeline after a collector who skipped the bluing agent). The follow-on Program Design and Audit action is what oral-fluid implementation lead does next: implement the option, assign an owner, and log the missing fact.